/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

LUCID DIAGNOSTICS INC.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.04 0.0297(2.97%) LUCD at 04 Dec 2025 04:38 PM Medical Devices
Lowest Today 0.9923
Highest Today 1.04
Today’s Open 1.02
Prev. Close 1.01
52 Week High 1.80
52 Week Low 0.75
Day’s Range: Low 0.9923 High 1.04
52-Week Range: Low 0.75 High 1.80
1 day return -
1 Week return -1.42
1 month return -6.75
3 month return -25.0
6 month return -15.85
1 year return +16.55
3 year return -46.37
5 year return -
10 year return -

Institutional Holdings

Vanguard Group Inc 4.05

BlackRock Inc 3.55

Masters Capital Management LLC 2.68

Vanguard Total Stock Mkt Idx Inv 2.06

Geode Capital Management, LLC 1.55

iShares Russell 2000 ETF 1.47

Vanguard Institutional Extnd Mkt Idx Tr 0.85

Luminus Management, LLC 0.78

Alyeska Investment Group, L.P. 0.72

Fidelity Small Cap Index 0.67

State Street Corp 0.61

Northern Trust Corp 0.52

Morgan Stanley - Brokerage Accounts 0.46

Lido Advisors, LLC 0.38

Fidelity Extended Market Index 0.37

iShares Russell 2000 Value ETF 0.34

Vanguard Russell 2000 ETF 0.32

First Manhattan Co. LLC 0.32

Goldman Sachs Group Inc 0.30

iShares Russell 2000 Growth ETF 0.25

Nuveen, LLC 0.24

Renaissance Technologies Corp 0.24

State St Russell Sm Cap® Indx SL Cl I 0.24

Wells Fargo & Co 0.22

XML Financial, LLC 0.18

Charles Schwab Investment Management Inc 0.17

Schwab Small Cap Index 0.17

NT R2000 Index Fund - NL 0.16

Bank of New York Mellon Corp 0.15

iShares Micro-Cap ETF 0.15

CREF Stock R3 0.15

Extended Equity Market Fund K 0.15

Fidelity Total Market Index 0.14

NT R2000 Index Fund - DC - NL - 3 0.13

Barclays PLC 0.12

Vanguard Balanced Index Inv 0.12

iShares Russell 2000 Small-Cap Idx Instl 0.12

Squarepoint Ops LLC 0.11

Russell 2500™ Index Fund F 0.11

Fidelity Series Total Market Index 0.10

Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 132.41 M

PB Ratio 2.159

PE Ratio 0.0

Enterprise Value 164.34 M

Total Assets 30.72 M

Volume 738609

Company Financials

Annual Revenue FY23:1500000 1.5M, FY22:377000 0.4M, FY21:500000 0.5M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:-4640000 -4.6M, FY22:-3237000 -3.2M, FY21:-85000 -0.1M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-56764000 -56.8M, FY22:-56171000 -56.2M, FY21:-28737000 -28.7M, FY20:-8279517 -8.3M, FY19:-4420544 -4.4M

Quarterly Revenue Q3/2025:1211000000 1211.0M, Q2/2025:1163000 1.2M, Q1/2025:828000 0.8M, Q3/2024:1172000 1.2M, Q2/2024:976000 1.0M

Quarterly Profit Q3/2025:-486000000 -486.0M, Q2/2025:-622000 -0.6M, Q1/2025:-723000 -0.7M, Q3/2024:-512000 -0.5M, Q2/2024:-867000 -0.9M

Quarterly Net worth Q3/2025:-10397000000 -10397.0M, Q2/2025:-4439000 -4.4M, Q1/2025:-26908000 -26.9M, Q3/2024:-12371000 -12.4M, Q2/2024:-11005000 -11.0M

Fund house & investment objective

Company Information Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Organisation Medical Devices

Employees 72

Industry Medical Devices

CEO Dr. Lishan Aklog M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow